VAQTA 50 [iU]/mL

VAQTA 50 [iU]/mL is an inactivated hepatitis A vaccine designed to prevent hepatitis A virus infection. This intramuscular injection is suitable for individuals seeking protection against hepatitis A.

VAQTA 50 [iU]/mL is primarily used for the prevention of hepatitis A, a viral liver disease. This vaccine is often recommended for people traveling to areas with high rates of hepatitis A, as well as for those who may be at increased risk of infection due to their occupation or lifestyle. The vaccine works by stimulating the body's immune response to develop protection against the hepatitis A virus.

Common effects of VAQTA 50 [iU]/mL may include soreness, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or fatigue following vaccination. These effects are typically temporary and resolve on their own within a few days.

VAQTA 50 [iU]/mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform your healthcare provider about any current medications or health conditions before receiving the vaccine.

VAQTA 50 [iU]/mL may interact with certain medications or other vaccines. It is advisable to discuss any ongoing treatments or recent vaccinations with a healthcare provider to ensure safe administration. Alcohol and other substances should be considered, as they might affect the immune response.